Comparative assessment of glycosylation of recombinant human ...（五）
Supporting Information
(1) RP-UPLC-Q-TOF analysis of hFSHs subunits; (2) molecular weights and possible glycan structures of hFSHs subunits; (3) profiling and relative quantification of N-glycans of hFSHs; (4) site-specific characterization of N-glycosylation of rhFSH and uhFSH.
Acknowledgments
This work was supported by Shanghai Sailing Program (15YF1410900), Shanghai Technology Standard Program (14DZ0502100).The authors declare no competing financial interest.
References
(1) Grass, J.; Pabst, M.; Chang, M.; Wozny, M.; Altmann, F. Analysis of recombinant human follicle-stimulating hormone (FSH) by mass spectrometric approaches. Anal.Bioanal. Chem. 2011, 400, 2427–2438.
(2) Green, E. D.; Baenziger, J. U. Asparagine-linked oligosaccharides on lutropin,
follitropin, and thyrotropin. II. Distributions of sulfated and sialylated oligosaccharides on bovine, ovine, and human pituitary glycoprotein hormones. J. Biol. Chem. 1988, 263,36–44.
(3) Lispi, M.; Bassett, R.; Crisci, C.; Mancinelli, M.; Martelli, F.; Ceccarelli, D.; De Bellis, C.;
Mendola, D. Comparative assessment of the consistency and quality of a highly purified FSH extracted from human urine (urofollitropin) and a recombinant human FSH (follitropin α). Reprod. BioMed. Online 2006, 13, 179–193.
(4) Selman, H.; Pacchiarotti, A.; El-Danasouri, I. Ovarian stimulation protocols based on follicle-stimulating hormone glycosylation pattern: impact on oocyte quality and clinical outcome. Fertil. Steril. 2010, 94, 1782–1786.
(5) Li, H. J.; d’Anjou, M. Pharmacological significance of glycosylation in therapeutic. Curr.Opin. Biotechnol. 2009, 20, 678–684.
(6) Ulloa-Aguirre, A.; Timossi, C.; Damian-Matsumura, P.; Dias J. A. Role of glycosylation in function of follicle-stimulating hormone. Endocrine 1999, 11, 205–215.
(7) Loreti, N.; Fresno, C.; Barrera, D.; Andreone, L.; Albarran, S. L.; Fernandez, E, A.;Larrea, F.; Campo, S. The glycan structure in recombinant human FSH affects endocrine activity and global gene expression in human granulosa cells. Mol. Cell. Endocrinol. 2013,366, 68–80.
(8) Loreti, N.; Ambao, V.; Andreone, L.; Trigo, R.; Bussmann, U.; Campo, S. Effect of sialylation and complexity of FSH oligosaccharides on inhibin production by granulosa cells. Reproduction 2013, 145, 127–135.
(9) D’Antonio, M.; Borrelli, F.; Datola, A.; Bucci, R.; Mascia, M.; Polletta, P.; Piscitelli, D.;
Papoian, R. Biological characterization of recombinant human follicle stimulating hormone isoforms. Hum. Reprod. 1999, 14, 1160–1167.
(10) Vitt, U. A.; Kloosterboer, H. J.; Rose, U. M.; Mulders, J.W.; Kiesel, P. S.; Bete, S.;Nayudu, P. L. Isoforms of human recombinant follicle-stimulating hormone: comparison of effects on murine follicle development in vitro. Biol. Reprod. 1998, 59, 854–861.
(11) Barrios-de-Tomasi, J.; Timossi, C.; Merchant, H.; Quintanar, A.; Avalos, J. M.;Andersen, C. Y.; Ulloa-Aguirre, A. Assessment of the in vitro and in vivo biological activities of the human follicle-stimulating isohormones. Mol. Cell. Endocrinol. 2002, 186,189–198.
(12) Marino, K.; Bones, J.; Kattla, J. J.; Rudd, P. M. A systematic approach to protein glycosylation analysis: a path through the maze. Nat. Chem. Biol. 2010, 6, 713–723.
(13) Lombardi, A.; Andreozzi, C.; Pavone, V.; Triglione, V.; Angiolini, L.; Caccia, P.Evaluation of the oligosaccharide composition of commercial follicle stimulating hormone preparations. Electrophoresis 2013, 34, 2394–2406.
(14) Gervais, A.; Hammel, Y. A.; Pelloux, S.; Lepage, P.; Baer, G.; Carte, N.; Sorokine, O.;Strub, J. M.; Koerner, R.; Leize, E.; Van Dorsselaer, A. Glycosylation of human recombinant gonadotrophins: characterization and batch-to-batch consistency.Glycobiology 2003, 13, 179–189.
(15) Bousfield, G. R.; Butnev, V. Y.; Rueda-Santos, M. A.; Brown, A.; Hall, A. S.; Harvey,D. J. Macro- and micro-heterogeneity in pituitary and urinary follicle-stimulating hormone glycosylation. J. Glycomics Lipidomics 2014, 4, 125.
(16) Liu, C.; Dong, S.; Xu, X. J.; Yin, Y.; Shriver, Z.; Capila, I.; Myette J.; Venkataraman G. Assessment of the quality and structural integrity of a complex glycoprotein mixture following extraction from the formulated biopharmaceutical drug product. J. Pharm.Biomed. Anal. 2011, 54, 27–36.
(17) Nuck, R. Enzymatical hydrolysis of N-glycans from glycoproteins and fluorescent labeling by 2-aminobenzamide (2-AB). Methods Mol. Biol. 2008, 446, 231–238.
(18) Ahn, J.; Bones, J.; Yu, Y. Q.; Rudd, P. M.; Gilar, M. Separation of 2-aminobenzamide labeled glycans using hydrophilic interaction chromatography columns packed with 1.7 microm sorbent. J. Chromatogr. B 2010, 878, 403−408.
(19) Telford, J. E.; Bones, J.; McManus, C.; Saldova, R.; Manning, G.; Doherty, M.;Leweke, F. M.; Rothermundt, M.; Guest, P. C.; Rahmoune, H.; Bahn, S.; Rudd, P. M. Antipsychotic treatment of acute paranoid schizophrenia patients with olanzapine results in altered glycosylation of serum glycoproteins. J. Proteome Res. 2012, 11, 3743–3752.
(20) Houel S.; Hilliard M.; Yu Y. Q.; Mcloughlin N.; Martin S. M.; Rudd P. M.; Williams J. P.;Chen, W. N- and O-glycosylation analysis of etanercept using liquid chromatography and quadrupole time-of-flight mass spectrometry equipped with electron-transfer dissociation functionality. Anal. Chem. 2014, 86, 576−584.
(21) Gilar, M.; Yu, Y. Q.; Ahn, J.; Xie, H.; Han, H.; Ying, W.; Qian, X. Characterization of glycoprotein digests with hydrophilic interaction chromatography and mass spectrometry.Anal. Biochem. 2011, 417, 80–88.
-
会议会展
